leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC
cell karyotype
cancer
cell lineage
mesoderm
cell sex
F
treatment
None
treatment description
No special treatment or protocol applies
antibody
TFIIIC-110
antibody antibodydescription
rabbit polyclonal. Antibody Target: TFIIIC-110
antibody targetdescription
TFIIIC-110 is a subunit of the RNA Polymerase III transcription factor TFIIIC. Antiserum 4286 was raised by immunizing rabbits with synthetic peptide RPGFSPTSHRLLPTP (human TFIIIC110 residues 897 to 911) coupled to keyhole limpet hemocyanin.
antibody vendorname
Dr. Robert J. White, Beatson Institute for Cancer Research, UK
antibody vendorid
4286
control
std
control description
Standard input signal for most experiments.
control
std
control description
Standard input signal for most experiments.
controlid
wgEncodeEH000615
labversion
remapped from hg18, Illumina 2.0, low confidence sequences excluded